Retinal vasproliferative tumor in a case of X-linked retinoschisis detachment
| Autor: | Audina M. Berrocal, Nimesh A. Patel, Kimberly D. Tran, Stanley Chang, Diana M. Laura, Gaetano R. Barile |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Pars plana medicine.medical_specialty Bevacizumab medicine.medical_treatment Retinoschisis Vitrectomy Vasproliferative tumor 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine lcsh:Ophthalmology Ophthalmology Case report medicine medicine.diagnostic_test business.industry Retinal detachment Retinal medicine.disease Fluorescein angiography Vascular endothelial growth factor 030104 developmental biology medicine.anatomical_structure chemistry lcsh:RE1-994 030221 ophthalmology & optometry business X-linked retinoschisis medicine.drug |
| Zdroj: | American Journal of Ophthalmology Case Reports American Journal of Ophthalmology Case Reports, Vol 9, Iss C, Pp 48-50 (2018) |
| ISSN: | 2451-9936 |
| DOI: | 10.1016/j.ajoc.2018.01.002 |
| Popis: | Purpose To describe the first published case of X-linked retinoschisis (XLRS) detachment with retinal vasoproliferative tumor (RVPT) and provide a literature review of the subject. Observations The authors describe a case of a 17 year old male with X-linked retinoschisis who presented with a retinal detachment and a retinal vasoproliferative tumor. The patient was treated with pars plana vitrectomy, endolaser, subtenon's kenalog and anti-VEGF (vascular endothelial growth factor) intravitreal injections. He regained 20/60 vision with a flat macula and had significant resolution of the associated vasoproliferative leakage seen on fluorescein angiography. Conclusions and importance This case adds XLRS to the conditions associated with RVPT and gives support for treatment with laser photocoagulation and anti-VEGF therapy with bevacizumab to control the exudative process. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|